The ballot initiative drawing the most spending on the November ballot would not affect the average Californian, but drug companies have a major stake and are spending heavily to defeat it. The ballot measure affects only drug coverage for a fraction of Californians, who account for about $3.8 billion in drug spending. A third of those drugs would be cheaper if VA price were applied, and they estimated that getting VA price applied to those drugs could save about $100 to $125 million in 2014. This ad in support of California ballot initiative Proposition 61 depicts Pfizer CEO Ian Read as a criminal. (Yes on prop 61)Read More:Why America pays so much more for drugsThe bizarre reason two competing drug prices rose in tandem

Source: Washington Post November 08, 2016 15:10 UTC